Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Migraine trials: crossover or parallel group?

J A Lewis1

  • 1ICI Pharmaceuticals Division, Macclesfield, Cheshire, UK.

Neuroepidemiology
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seed Treatment with a Fungal or a Bacterial Antagonist for Reducing Corn Damping-off Caused by Species of Pythium and Fusarium.

Plant disease·2019
Same author

Seed Treatment Using Pre-infiltration and Biocontrol Agents to Reduce Damping-off of Corn Caused by Species of Pythium and Fusarium.

Plant disease·2019
Same author

A Formulation of Trichoderma and Gliocladium to Reduce Damping-off Caused by Rhizoctonia solani and Saprophytic Growth of the Pathogen in Soilless Mix.

Plant disease·2019
Same author

3D printed structures for modeling the Young's modulus of bamboo parenchyma.

Acta biomaterialia·2018
Same author

Tactic-specific benefits of polyandry in Chinook salmon Oncorhynchus tshawytscha.

Journal of fish biology·2016
Same author

Evaluation of the Pulmonary Toxicity of Ambient Particulate Matter From Camp Victory, Iraq.

Journal of toxicology and environmental health. Part A·2015
Same journal

Changing Referral Patterns in Paediatric Neurology: A Tertiary Outpatient Study within Brazil's Unified Health System, 2014-2024.

Neuroepidemiology·2026
Same journal

Diverging trajectories of multiple sclerosis burden in postmenopausal women across East Asia: a comparative analysis of China, Japan, and the Republic of Korea from 1990 to 2050.

Neuroepidemiology·2026
Same journal

Sex-Specific Modifiable Factors for Incident Late-Onset Dementia in the Geographic Context: A Longitudinal Comparative Analysis of Multicohort Studies across 19 Countries.

Neuroepidemiology·2026
Same journal

Global prevalence of epilepsy and temporal trends, 1980-2025: a systematic review and meta-analysis.

Neuroepidemiology·2026
Same journal

Neurobrucellosis: A Narrative Review.

Neuroepidemiology·2026
Same journal

Health-Related Quality of Life and Family Impact Among Children with Epilepsy: The Role of Seizure Control.

Neuroepidemiology·2026
See all related articles

For migraine prophylaxis, parallel group trials are preferred over crossover designs due to time-varying effects and carry-over concerns. Parallel group trials offer a robust evaluation of migraine treatment efficacy.

Area of Science:

  • Clinical Trials Methodology
  • Neurology
  • Pharmacotherapy

Background:

  • Evaluating migraine therapy requires careful consideration of clinical trial designs.
  • Both crossover and parallel group designs have been utilized for migraine treatment studies.

Purpose of the Study:

  • To compare the relative merits of crossover and parallel group designs for evaluating migraine prophylaxis.
  • To identify key factors influencing the choice of trial design in migraine therapy evaluation.

Main Methods:

  • Comparative analysis of crossover and parallel group trial designs.
  • Focus on specific challenges in migraine prophylaxis trials: time-varying treatment effects, carry-over effects, and patient withdrawals.

Main Results:

Related Experiment Videos

  • Parallel group trials are preferred for migraine prophylaxis due to issues with time-varying treatment effects, carry-over, and handling of withdrawals.
  • The power advantage of crossover designs is often minimal when baseline data is available.
  • Parallel group designs are suitable for evaluating acute migraine therapies as well.

Conclusions:

  • Parallel group trials are the recommended design for evaluating migraine prophylactic treatments.
  • The choice of design should carefully weigh statistical power against practical considerations in clinical trials.